AC Immune SA Stock

Market capitalization is the stock price multiplied by the number of shares issued.

AC Immune SA

Enterprise value (EV) is a measure of the value of a company regardless of its financing. It is calculated as follows:
EV = market capitalization - cash + debt.

Enterprise Value metric explained

AC Immune SA

The P/E ratio or price/earnings ratio TTM (Trailing Twelve Months) over the last 12 months describes the ratio of the stock price to earnings per share.

AC Immune SA

If you divide the enterprise value by the Free Cash Flow of the last 12 months, you obtain an important metric for assessing the valuation of companies - even if they are not yet generating profits.

AC Immune SA

If you divide the enterprise value by the revenue of the last 12 months, you obtain an important metric for assessing the valuation of companies - even if they are not yet making a profit.

AC Immune SA

The KUV or price/sales ratio TTM (Trailing Twelve Months) over the last 12 months describes the ratio of the stock price to sales per share.

AC Immune SA

The P/B ratio TTM (Trailing Twelve Months) over the last 12 months describes the ratio of the stock price to the book value per share.

AC Immune SA

Sales growth TTM (Trailing Twelve Months) compares the sales of the last 12 months with the sales of the previous 12 months.

AC Immune SA

Revenue TTM (Trailing Twelve Months) represents the sum of all revenues of a company for its products, services or other items within the last 12 months.

AC Immune SA

EBIT or the operating result represents the profit or loss after deducting direct costs (cost of sales), sales, marketing, administrative, research and development costs and depreciation and amortization.

AC Immune SA

Cash is defined as cash and cash equivalents (i.e. cash items of very high value).

AC Immune SA

EPS TTM (Trailing Twelve Months) or earnings per share represents the profit per share over the last 12 months. The company's net profit is divided by the number of shares.

AC Immune SA

Price/earnings ratio based on the expected net earnings per share for the financial year ending at Dec 31 2025.

AC Immune SA

Ratio of market capitalization to sales on the basis of expected sales for the financial year ending at Dec 31 2025

AC Immune SA

Ratio of enterprise value to sales based on estimated sales for the financial year ending at Dec 31 2025

AC Immune SA